According to a research report published by J.P. Morgan Chase, insurance stocks listed in Hong Kong outperformed their Asia-Pacific peers in 2025. Among them, China Life Insurance rose 87%, outperforming the 28% increase in the Hang Seng Index. The bank expects 2026 to be a year where major life insurers' strong balance sheets, robust distribution channels, and optimized product portfolios will be recognized by the market. Ping An China was the bank's first choice, giving it an “increase in wealth” rating, and the target price was raised to HK$100. Next is China Life Insurance, with a target price of HK$40. The bank also upgraded Taibao's rating from “neutral” to “increased holdings”, reflecting its fundamental recovery. However, the downgrade of Xinhua Insurance's rating from “increased holdings” to “neutral” is mainly due to the widening gap in reserve quality compared to major life insurance companies after a strong rise in stock prices in 2025.

According to a research report published by J.P. Morgan Chase, insurance stocks listed in Hong Kong outperformed their Asia-Pacific peers in 2025. Among them, China Life Insurance rose 87%, outperforming the 28% increase in the Hang Seng Index. The bank expects 2026 to be a year where major life insurers' strong balance sheets, robust distribution channels, and optimized product portfolios will be recognized by the market. Ping An China was the bank's first choice, giving it an “increase in wealth” rating, and the target price was raised to HK$100. Next is China Life Insurance, with a target price of HK$40. The bank also upgraded Taibao's rating from “neutral” to “increased holdings”, reflecting its fundamental recovery. However, the downgrade of Xinhua Insurance's rating from “increased holdings” to “neutral” is mainly due to the widening gap in reserve quality compared to major life insurance companies after a strong rise in stock prices in 2025.